Last updated: July 17, 2026

Application No. 18/670,859

NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER

Non-Final OA

Filed

May 22, 2024

Priority

May 24, 2023 — provisional 63/504,099

Examiner

PATEL, SAGAR S

Art Unit

Tech Center

Assignee

Novartis AG

OA Round

1 (Non-Final)

Interview Optional

— +33.8% interview lift. Examiner has a relatively high allowance rate (76%); +33.8% interview lift. A written response may suffice.

Based on 463 resolved cases, 2023–2026

Examiner Intelligence

PATEL, SAGAR S View full profile →

Grants 76% — above average

Career Allowance Rate

353 granted / 463 resolved

+16.2% vs TC avg

Strong +34% interview lift

Without

With

+33.8%

Interview Lift

resolved cases with interview

Typical timeline

2y 6m

Avg Prosecution

31 currently pending

Career history

490

Total Applications

across all art units

Statute-Specific Performance

§101

0.7%

-39.3% vs TC avg

§103

60.8%

+20.8% vs TC avg

§102

14.9%

-25.1% vs TC avg

§112

8.5%

-31.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 463 resolved cases

Prosecution Timeline

May 22, 2024

Application Filed

May 20, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/657,052

Patent 12679809

CRYSTALLINE FORMS AND SALT FORMS OF A KINASE INHIBITOR

2y 2m to grant Granted Jul 14, 2026

17/797,760

Patent 12673963

CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS

3y 11m to grant Granted Jul 07, 2026

17/332,499

Patent 12667579

PHARMACEUTICAL COMPOSITIONS FOR CLINICAL NUTRITION

5y 1m to grant Granted Jun 30, 2026

17/741,153

Patent 12662477

Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative Diseases

4y 1m to grant Granted Jun 23, 2026

17/923,834

Patent 12660499

ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, DISPLAY DEVICE, LIGHTING DEVICE

3y 7m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

76%

Grant Probability

99%

With Interview (+33.8%)

2y 6m (~4m remaining)

Median Time to Grant

Low

PTA Risk

Based on 463 resolved cases by this examiner. Grant probability derived from career allowance rate.